Marie Kveiborg

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsRadiation therapyInnate immunityProteomics and intermolecular interactions (excl. medical proteomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 21, 2023
Loss of cancer cell-derived ADAM15 alters the tumor microenvironment in colorectal tumors.

Laia Puig-Blasco, Krzysztof B Piotrowski, Signe R Michaelsen

|Jul 26, 2023
ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy.

Krzysztof Bartłomiej Piotrowski, Laia Puig Blasco, Jacob Samsøe-Petersen

|Jun 24, 2020
ADAM12 is a costimulatory molecule that determines Th1 cell fate and mediates tissue inflammation.

Yawei Liu, Robert Bockermann, Mahdieh Hadi

|May 14, 2020
Mechanisms of site-specific dephosphorylation and kinase opposition imposed by PP2A regulatory subunits.

Thomas Kruse, Sebastian Peter Gnosa, Isha Nasa

|Apr 25, 2019
Identification of ADAM12 as a Novel Basigin Sheddase.

Reidar Albrechtsen, Nicolai J Wewer Albrechtsen, Sebastian Gnosa

|Nov 17, 2017
Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration.

Kasper J Mygind, Jeanette Schwarz, Pranshu Sahgal

Pageof 1

Frequent Collaborators

1 joint publications

Nicolai J Wewer Albrechtsen

1 joint publications

Lars Dyrskjøt

1 joint publications

Thomas Kruse

1 joint publications

Denise Nikodemus